ADDS 2022 Sponsors
Platinum Level Sponsor
Koneksa is the digital biomarker company. Koneksa's primary focus is the support of industry-sponsored clinical research in the development of novel therapies using digital measures. We differentiate ourselves through a unique combination of science, software, and services.
We lead with science, focusing on the intersection of clinical objectives, scientific literature, and our experience to help you design a study which supports your drug-development objectives.
We scale with software, deploying digital biomarkers through a software subscription to our global study execution platform, and we support with services to ensure seamless setup and execution of your study.
We recognize that digital studies can generate significantly more data than traditional clinic-visit-based studies. Therefore, we also provide statistical and scientific services to help you analyze the study dataset and get the most out of your investment in our capabilities to collect digital measures.
Koneksa has executed more than 40 clinical studies worldwide involving more than 4,500 patients contributing mobile, wearable, and actigraphy measures across all therapeutic areas. Koneksa routinely supports studies with 12 of the top 20 pharma by R&D spend, working across all phases of development and across the full hierarchy of endpoints as well as a growing number of smaller biotechs.